Purpose and Scope
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations on the management of primary cutaneous lymphoma in the U.K. The document aims to: (i) offer an appraisal of all relevant literature up to February 2018 focusing on any key developments; (ii) address important, practical clinical questions relating to the primary guideline objective; (iii) provide guideline recommendations with, where appropriate, some health economic implications; and (iv) discuss potential developments and future directions.
The guideline is presented as a detailed review with highlighted recommendations for practical use in the clinic (see section 12). A patient information leaflet on mycosis fungoides is available on the British Association of Dermatologists (BAD) website: www.bad.org.uk/for-the-public/patient-information-leaflets. Further information can also be found at www.lymphomas.org.uk/about-lymphoma.
Exclusions
These guidelines do not cover patients presenting with or found to have skin involvement as part of a systemic lymphoma.
The British Journal of Dermatology. 2019;180(3):496-526. © 2019 Blackwell Publishing
Comments